Hiroshi Maeda
Sojo University, Japan
Biography
Hiroshi Maeda is a world renowned expert in macromolecular therapeutics. He was successful in creating theworld first polymeric drug, SMANCS, approved for treatment of hepatoma in Japan. Consequently, he discovered the concept of EPR effect of macromolecular-drugs, ubiquitous mechanism for solid tumor selective targeting of polymeric drugs. He received MS, University of California, Fulbright Fellow, and PhD, MD, Tohoku University. He published more than 450 papers in reputed journals. He was awarded Lifetime-Achievement-Award at Royal-Pharmaceutical-Society, Princess-Takamatsu-Award in Cancer Research, Tomizo-Yoshida-Award, highest award of Japan-Cancer-Assoc., and was also selected as most cited influential scientist in pharmacology by Thomson Reuters 2014.